Working… Menu

A Study of ABTL0812 in Pancreatic Cancer (Pancreatic)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03417921
Recruitment Status : Not yet recruiting
First Posted : January 31, 2018
Last Update Posted : June 25, 2019
The Cleveland Clinic
Information provided by (Responsible Party):
Ability Pharmaceuticals SL

No Study Results Posted on for this Study
Recruitment Status : Not yet recruiting
Estimated Primary Completion Date : March 30, 2022
Estimated Study Completion Date : March 30, 2023